Ocuphire Pharma, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Statement Of Stockholders' Equtiy

Statement Of Stockholders' Equtiy - USD ($)	3 Months Ended				12 Months Ended
Statement Of Stockholders' Equtiy - USD ($)	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Balance		$ 26,580,491		$ 12,625,488	$ 26,580,491	$ 12,625,488	$ 9,533,989
Balance, shares		178,253,318			178,253,318
Issuance of common stock and units					$ 5,250,073	16,308,572	8,633,855
Stock issuance costs					(566,065)	(1,159,582)	(952,490)
Common stock issued in exchange for services, value					$ 102,000	$ 409,000	$ 306,800
Common stock issued in exchange for services, shares					150,000	400,000	640,000
Shares surrendered for net stock option exercise						$ (100,000)
Stock options exercised					$ 708,617	$ 358,955	$ 90,000
Stock options exercised, shares					889,428	448,693	375,000
Stock warrants exercised					$ 31,703	$ 16,084,511	$ 3,947,330
Stock warrants exercised, shares					47,300	11,738,220	4,681,497
Stock based compensation					$ 1,037,679	$ 608,795	$ 565,428
Net Loss	$ (2,852,155)	$ (4,271,711)	$ (2,210,118)	(14,600,499)	(14,384,556)	(18,521,601)	(9,499,424)
Other Comprehensive Loss					$ 15,606	$ (33,647)
Balance, shares	197,413,785		178,253,318		197,413,785	178,253,318
Balance	$ 18,775,548		$ 26,580,491		$ 18,775,548	$ 26,580,491	12,625,488
Common Stock [Member]
Balance		$ 17,837		$ 14,673	$ 17,837	$ 14,673	$ 11,944
Balance, shares		178,366,533		146,732,000	178,366,533	146,732,000	119,443,194
Issuance of common stock and units					$ 1,807	$ 1,905	$ 2,159
Issuance of common stock and units, Shares					18,073,739	19,047,620	21,592,309
Common stock issued in exchange for services, value					$ 15	$ 40	$ 64
Common stock issued in exchange for services, shares					150,000	400,000	640,000
Stock options exercised					$ 89	$ 45	$ 38
Stock options exercised, shares					889,428	448,693	375,000
Stock warrants exercised					$ 4	$ 1,174	$ 468
Stock warrants exercised, shares					47,300	11,738,220	4,681,497
Retirement of treasury stock					$ (11)
Retirement of treasury stock, shares					(113,215)
Balance, shares	197,413,785		178,366,533		197,413,785	178,366,533	146,732,000
Balance	$ 19,741		$ 17,837		$ 19,741	$ 17,837	$ 14,673
Additional Paid-in Capital [Member]
Balance		$ 118,057,019		$ 85,449,932	118,057,019	85,449,932	72,861,738
Issuance of common stock and units					5,248,266	16,306,667	8,631,696
Stock issuance costs					(566,065)	(1,159,582)	(952,490)
Common stock issued in exchange for services, value					101,985	408,960	306,736
Stock options exercised					708,528	358,910	89,962
Stock warrants exercised					31,699	16,083,337	3,946,862
Stock based compensation					1,037,679	608,795	565,428
Retirement of treasury stock					(128,399)
Balance	124,490,712		118,057,019		124,490,712	118,057,019	85,449,932
Accumulated Deficit [Member]
Balance		(91,332,308)		(72,810,707)	(91,332,308)	(72,810,707)	(63,311,283)
Net Loss					(14,384,556)	(18,521,601)	(9,499,424)
Balance	(105,716,864)		$ (91,332,308)		(105,716,864)	(91,332,308)	(72,810,707)
Treasury Stock [Member]
Balance		$ (128,410)		$ (28,410)	$ (128,410)	$ (28,410)	$ (28,410)
Balance, shares		113,215		14,205	113,215	14,205	14,205
Shares surrendered for net stock option exercise						$ (100,000)
Shares surrendered for net stock option exercise, Shares						99,010
Stock options exercised, shares
Retirement of treasury stock					$ 128,410
Retirement of treasury stock, shares					(113,215)
Balance, shares			113,215			113,215	14,205
Balance			$ (128,410)			$ (128,410)	$ (28,410)
Accumulated Other Comprehensive Loss [Member]
Balance		$ (33,647)			$ (33,647)
Other Comprehensive Loss					15,606	(33,647)
Balance	$ (18,041)		$ (33,647)		$ (18,041)	$ (33,647)